Flexible, sticky, and biodegradable wireless device for drug delivery to brain tumors.

Lee J, Cho HR, Cha GD, Seo H, Lee S, Park CK, Kim JW, Qiao S, Wang L, Kang D, Kang T, Ichikawa T, Kim J, Lee H, Lee W, Kim S, Lee ST, Lu N, Hyeon T, Choi SH, Kim DH.

Nat Commun. 2019 Nov 15;10(1):5205. doi: 10.1038/s41467-019-13198-y. 2019 11;

Decreased APE-1 by Nitroxoline Enhances Therapeutic Effect in a Temozolomide-resistant Glioblastoma: Correlation with Diffusion Weighted Imaging.

Cho HR, Kumari N, Thakur N, Vu HT, Kim H, Choi SH.

Sci Rep. 2019 Nov 12;9(1):16613. doi: 10.1038/s41598-019-53147-9. 2019 11;

Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI.

Cho HR, Kumari N, Thi Vu H, Kim H, Park CK, Choi SH.

Sci Rep. 2019 Jul 31;9(1):11085. doi: 10.1038/s41598-019-47438-4. 2019 7;

Positional effect of preoperative neuronavigational magnetic resonance image on accuracy of posterior fossa lesion localization.

Dho YS, Kim YJ, Kim KG, Hwang SH, Kim KH, Kim JW, Kim YH, Choi SH, Park CK.

J Neurosurg. 2019 Jul 19:1-10. doi: 10.3171/2019.4.JNS1989 2019 7;

Altered Vascular Permeability in Migraine-associated Brain Regions: Evaluation with Dynamic Contrast-enhanced MRI.

Kim YS, Kim M, Choi SH, You SH, Yoo RE, Kang KM, Yun TJ, Lee ST, Moon J, Shin YW.

Radiology. 2019 Sep;292(3):713-720. doi: 10.1148/radiol.2019182566. Epub 2019 Jul 2. 2019 9;

Rapid framework for quantitative magnetization transfer imaging with interslice magnetization transfer and dictionary-driven fitting approaches.

Kim JW, Lee SL, Choi SH, Park SH.

Magn Reson Med. 2019 Nov;82(5):1671-1683. doi: 10.1002/mrm.27850. Epub 2019 Jun 10. 2019 11;

Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network.

Choi KS, Choi SH, Jeong B

Neuro Oncol. 2019 May 24. pii: noz095. doi: 10.1093/neuonc/noz095. 2019 5;

Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma.

Kim WJ, Dho YS, Ock CY, Kim JW, Choi SH, Lee ST, Kim IH, Kim TM, Park CK.

J Neurooncol. 2019 Jun;143(2):321-328. doi: 10.1007/s11060-019-03167-2. Epub 2019 Apr 13 2019 6;

Assessment of Early Therapeutic Response to Nitroxoline in Temozolomide-Resistant Glioblastoma by Amide Proton Transfer Imaging: A Preliminary Comparative Study with Diffusion-weighted Imaging.

Kumari, Thakur, Cho HR, Choi SH

Sci Rep. 2019 Apr 3;9(1):5585. doi: 10.1038/s41598-019-42088-y. 2019 4;

Evaluation of Tumor Blood Flow Using Alternate Ascending/Descending Directional Navigation in Primary Brain Tumors: A Comparison Study with Dynamic Susceptibility Contrast Magnetic Resonance Imaging.

Park H, Lee J, Park SH, Choi SH.

Korean J Radiol. 2019 Feb;20(2):275-282. doi: 10.3348/kjr.2018.0300. 2019 2;

Radiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and Prognosis.

Cho HR, Jeon H, Park CK, Park SH, Choi SH.

Sci Rep. 2018 Oct 30;8(1):16022. doi: 10.1038/s41598-018-34242-9. 2018 10;

Simultaneous Variable-Slab Dual-Echo TOF MR Angiography and Susceptibility-Weighted Imaging.

Do WJ, Choi SH, Park SH.

IEEE Trans Med Imaging. 2018 Jul;37(7):1632-1640. doi: 10.1109/TMI.2018.2789923. 2018 7;

BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients.

Cho HR, Jeon H, Park CK, Park SH, Kang KM, Choi SH.

Sci Rep. 2017 Dec 18;7(1):17740. doi: 10.1038/s41598-017-17062-1. 2017 12;

Glutaminase 2 expression is associated with regional heterogeneity of 5-aminolevulinic acid fluorescence in glioblastoma.

Kim S, Kim JE, Kim YH, Hwang T, Kim SK, Xu WJ, Shin JY, Kim JI, Choi H, Kim HC, Cho HR, Choi A, Chowdhury T, Seo Y, Dho YS, Kim JW, Kim DG, Park SH, Kim H, Choi SH, Park S, Lee SH, Park CK.

Sci Rep. 2017 Sep 22;7(1):12221. doi: 10.1038/s41598-017-12557-3. 2017 9;

Multiplexible Wash-Free Immunoassay Using Colloidal Assemblies of Magnetic and Photoluminescent Nanoparticles.

Kim D, Kwon HJ, Shin K, Kim J, Yoo RE, Choi SH, Soh M, Kang T, Han SI, Hyeon T.

ACS Nano. 2017 Aug 22;11(8):8448-8455. doi: 10.1021/acsnano.7b04088. Epub 2017 Aug 11. 2017 8;

Continuous O2-Evolving MnFe2O4 Nanoparticle-Anchored Mesoporous Silica Nanoparticles for Efficient Photodynamic Therapy in Hypoxic Cancer.

Kim J, Cho HR, Jeon H, Kim D, Song C, Lee N, Choi SH, Hyeon T.

J Am Chem Soc. 2017 Aug 16;139(32):10992-10995. doi: 10.1021/jacs.7b05559. Epub 2017 Aug 3. 2017 8;

Investigation of control scans in pseudo-continuous arterial spin labeling (pCASL): Strategies for improving sensitivity and reliability of pCASL.

Han PK, Choi SH, Park SH.

Magn Reson Med. 2016 Sep 30. doi: 10.1002/mrm.26474. [Epub ahead of print] 2016 9;

Underexpression of HOXA11 is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.

Se YB, Kim SH, Kim JY, Kim JE, Dho YS, Kim JW, Kim YH, Woo HG, Kim SH, Kang SH, Kim HJ, Kim TM, Lee ST, Choi SH, Park SH, Kim IH, Kim DG, Park CK.

Cancer Res Treat. 2016 Jul 19. doi: 10.4143/crt.2016.106. [Epub ahead of print] 2016 7;

Single and double acquisition strategies for compensation of artifacts from eddy current and transient oscillation in balanced steady-state free precession.

Lee HS, Choi SH, Park SH.

Magn Reson Med. 2016 Jul 15. doi: 10.1002/mrm.26338. [Epub ahead of print] 2016 7;

Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging

Hye Rim Cho, Bora Hong, Hyeonjin Kim, Chul-Kee Park, Sung-Hye Park, Sunghyouk Park, Seung Hong Choi

Oncotarget, Advance Publications 2016 2016 9;